L'adresse IP principale: 151.80.164.204,Votre serveur France,Roubaix
ISP:Privatecloud ID TLD:com Code postal:fr
Ce rapport est mis à jour en 08-Aug-2018
Created Date:
2002-09-25
Changed Date:
2017-02-28
Données techniques du genomicvision.com
Geo IP vous fournit comme la latitude, la longitude et l'ISP (Internet Service Provider) etc. informations.
Notre service GeoIP a trouvé l'hôte genomicvision.com.Actuellement, hébergé dans France et son fournisseur de services est Privatecloud ID .
Les informations d'en-tête HTTP font partie du protocole HTTP que le navigateur d'un utilisateur envoie à appelé Apache/2.4.29 (FreeBSD) OpenSSL/1.0.1s-freebsd PHP/7.1.11 contenant les détails de ce que le navigateur veut et acceptera de nouveau du serveur Web.
MX preference = 20, mail exchanger = d48.altospam.com. MX preference = 50, mail exchanger = u26.altospam.net.
HtmlToText
contact us • gv store • events • en • fr technology • products & services • clinical • life sciences • company • investors • technology molecular combing genomic morse code products & services discover the molecular combing platform molecular combing system scanner software dna extraction kit accessories downloads browse our genomic morse code sets fshd brca hnpcc explore our services quality control for genome engineering molecular combing services clinical diagnostic muscular dystrophy clinical research breast and ovarian cancer colorectal cancer life sciences dynamic studies of dna replication dna structural analysis company about us management executive board supervisory board scientific board news & events r&d; day upcoming events careers find our partners investors newsletter actionnaires corporate presentation press releases calendar media regulated information general assembly stock information contacts contact us gv store events bring a new perspective to genetic testing detection of structural variations involved in hereditary diseases the molecular combing technology, through an accurate single dna molecule analysis approach, responds to recurrent challenges in molecular diagnostics, including the detection of large genomic rearrangements and complex structural variations. genomic vision provides objective and comprehensive means to genetic diagnostic and offers a new perspective in molecular analysis. discover watch the video a panoramic view across the whole genome from physical mapping of dna over large regions of interests, to dynamic studies of dna replication genomic vision’s proprietary single dna analysis technology combines molecular combing; isolation and linearization genomic dna, with a unique targeting and detection strategy, the genomic morse code. genomic vision offers a versatile approach to probe the genome and gain insight into the structure and function of targeted areas. discover our technology muscular distrophy genomic vision’s diagnostic test facilitates the clear and precise identification of the fshd-specific repeat within its specific genomic environment. breast & ovarian cancer genomic vision offers a powerful approach for an accurate detection of large genomic rearrangements in both brca genes. the fiberprobes®brca genomic morse code set opens new possibilities for the studies of breast and ovarian cancer predisposition. replication combing assay the replication combing assay (rca) provides a unique, high resolution, single molecule approach to monitor both spatial and temporal characteristics of dna replication in a single experiment. gv store genomic vision launches "gv store" online store to support sales of product and services from lsr activities. fibervision ® molecular combing platform we pioneered the development of the molecular combing platform based on our direct dna analysis technology: a set of state-of-the-art tools that facilitates a standardized workflow from dna extraction to data analysis, while resolving important limitations of other dna fiber assays. learn more molecular combing a proprietary technique to untangle single dna molecules for direct visualization and analysis molecular combing is a user-friendly procedure for the stretching and assembly of millions of large dna fragments. the dna is attached and “combed” on a specially-treated glass surface using an automated process. genomic morse code a unique language for a clear understanding of dna modifications we have developed a unique proprietary detection strategy called the genomic morse code (gmc) for comprehensive analysis and physical mapping of target regions on stretched dna. technology investors products & services support life sciences contact us clinical legal terms company general terms & conditions of sale follow us english français ( french )
Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
Nous utilisons des cookies pour personnaliser votre expérience sur notre site. En poursuivant votre navigation, vous acceptez cette utilisation. Apprendre encore plus
genomicvision.com rapport :
Visitez le site